Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Succimer |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tiopronin |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deferoxamine (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trientine (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dimercaprol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Heavy metal antagonist-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
dimercaprol 50 mg/mL, ampoule de 2 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine [metabolic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium fluoride 1.2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium fluoride 2.0% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Edetate disodium 150mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium fluoride 1.23% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium fluoride 1.1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by heavy metal antagonist (disorder) |
Causative agent (attribute) |
True |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Edetate calcium disodium (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentetate calcium trisodium |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentetate zinc trisodium (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dimercaprol (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillamine |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium calcium edetate (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deferasirox (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentetic acid (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Administration of heavy metal antagonist |
Direct substance |
True |
Heavy metal antagonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |